Who are likely medtech winners in funding-constrained landscape?
This article was originally published in Clinica
Executive Summary
With healthcare funding pressures in developed markets unlikely to relent in the near-term, manufacturers of consumer-exposed devices are likely to fare better than traditional medtech companies that sell to hospitals.